Loading
Latest filing published 20 Jun 2026 for XSpray Pharma AB (publ), €4,377.
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Our data holds just one disclosure by Curt Mikael von Euler-Chelpin, dated 20 June 2026, reporting an open-market purchase worth €4,377 in XSpray Pharma AB (publ). Further filings will be added here. This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration